FC
XLRN

Ferris Capital’s Acceleron Pharma XLRN Stock Holding History

Ferris Capital’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-29
Closed -$1K – 665
2019
Q1 		$1K Hold
29
– – ﹤0.01% 666
2018
Q4 		$1K Hold
29
– – ﹤0.01% 657
2018
Q3 		$2K Hold
29
– – ﹤0.01% 647
2018
Q2 		$1K Hold
29
– – ﹤0.01% 672
2018
Q1 		$1K Buy
+29
New +$1.23K ﹤0.01% 688
2017
Q3 		– Sell
-29
Closed -$1K – 608
2017
Q2 		$1K Buy
+29
New +$840 ﹤0.01% 660

Other funds holding XLRN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Ferris Capital's XLRN Position: Q2 2019 in Review

Ferris Capital sold out of Acceleron Pharma (XLRN) in Q2 2019, closing a stake of 29 shares — an estimated $1K sold.

Ferris Capital first reported a position in XLRN in Q2 2017 and held it in 6 quarters. The position peaked at $2K in Q3 2018. 166 funds tracked by Wall St. Rank hold XLRN as of Q2 2019.

  • Ferris Capital reported no remaining Acceleron Pharma position as of Q2 2019 after selling out during the quarter.
  • Ferris Capital sold 29 Acceleron Pharma shares in Q2 2019, an estimated $1K.
  • Ferris Capital first reported a position in Acceleron Pharma in Q2 2017 and held it in 6 quarters.
  • Ferris Capital's Acceleron Pharma position peaked at $2K in Q3 2018.
  • 166 funds tracked by Wall St. Rank held Acceleron Pharma as of Q2 2019.

Based on Ferris Capital's 13F filing for Q2 2019, filed 18 Jul 2019.